Advertisement
Advertisement
NBIX
Neurocrine Biosciences Inc
133.25
USDSponsored
+4.84
+3.77%
Apr 17, 16:00 UTC -4
Closed
After-Market
132.82
-0.43
-0.32%
NBIX Earnings Reports
Positive Surprise Ratio
NBIX beat 16 of 40 last estimates.
40%
Next Report
Date of Next Report
May 05, 2026
Estimate for Q1 26 (Revenue/ EPS)
$790.14M
/$1.16
Implied change from Q4 25 (Revenue/ EPS)
-1.91%
/-21.62%
Implied change from Q1 25 (Revenue/ EPS)
+37.99%
/+1350.00%
Neurocrine Biosciences Inc earnings per share and revenue
On Feb 11, 2026, NBIX reported earnings of 1.48 USD per share (EPS) for Q4 25, missing the estimate of 1.91 USD, resulting in a -22.89% surprise. Revenue reached 805.50 million, compared to an expected 807.79 million, with a -0.28% difference. The market reacted with a -10.43% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 19 analysts forecast an EPS of 1.16 USD, with revenue projected to reach 790.14 million USD, implying an decrease of -21.62% EPS, and decrease of -1.91% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Evotec SE - ADR
Report Date
Apr 08, 2026 For Q4 25
Estimate
$0.31
Actual
$0.08
Surprise
-74.45%
Vivos Therapeutics, Inc. Common Stock
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$0.49
Actual
-$0.57
Surprise
-17.65%
Traws Pharma, Inc. Common Stock
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$1.24
Actual
$0.63
Surprise
+150.46%
Cosmos Holdings Inc. Common Stock
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.31
Surprise
-659.80%
BIOMERICA INC
Report Date
Apr 13, 2026 For Q3 26
Estimate
-Actual
-$0.44
Surprise
-
FAQ
What were Neurocrine Biosciences Inc's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Neurocrine Biosciences Inc reported EPS of $1.48, missing estimates by -22.89%, and revenue of $805.50M, -0.28% below expectations.
How did the market react to Neurocrine Biosciences Inc's Q4 2025 earnings?
The stock price moved down -10.43%, changed from $137.44 before the earnings release to $123.10 the day after.
When is Neurocrine Biosciences Inc expected to report next?
The next earning report is scheduled for May 05, 2026.
What are the forecasts for Neurocrine Biosciences Inc's next earnings report?
Based on 19
analysts, Neurocrine Biosciences Inc is expected to report EPS of $1.16 and revenue of $790.14M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement